DIURETICS


Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006. In the meantime, thank you for your patience.
BendroflumethiazideFor the treatment of high blood pressure and management of edema
BenzthiazideFor the treatment of high blood pressure and management of edema
BumetanideFor the treatment of edema associated with congestive heart failure, hepatic and
ChlorothiazideChlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
ChlorthalidoneFor management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.
EplerenoneFor improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction.
FurosemideFor treatment and management of Hypertension; Oedema; Renal failure; Oliguria
HydrochlorothiazideFor the treatment of high blood pressure and management of edema
Torasemide
TorsemideFor the treatment of hypertension, edema induced by congestive heart failure or renal disease and ascites assocated with hepatic disease
TriamtereneFor the treatment of oedema in congestive cardiac failure and renal and hepatic disease used with or without other diuretics to preserve potassium.
TrichlormethiazideUsed in the treatment of oedema (including that associated with heart failure) and hypertension.

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org